Aarti Drugs Limited (AARTIDRUGS.BO)
INR 330.65
(2.85%)
INR 330.65
(2.85%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 25.28 Billion | 27.16 Billion | 24.88 Billion | 21.54 Billion | 18.06 Billion | 15.6 Billion |
| Cost of Revenue | 16.96 Billion | 18.88 Billion | 19.84 Billion | 15.54 Billion | 14.01 Billion | 12.47 Billion |
| Gross Profit | 8.31 Billion | 8.27 Billion | 5.03 Billion | 6 Billion | 4.04 Billion | 3.13 Billion |
| Operating Expenses | 1.16 Billion | 5.72 Billion | 2.06 Billion | 2.05 Billion | 1.81 Billion | 1.42 Billion |
| Selling, General and Administrative Expenses | 1.04 Billion | 836.52 Million | 815.93 Million | 744.59 Million | 626.15 Million | 386.4 Million |
| Research and Development Expenses | 120.21 Million | 77.5 Million | 66.06 Million | 85.97 Million | 87.36 Million | 85.6 Million |
| Other Expenses | - | 21.9 Million | -45.63 Million | -27.39 Million | -20.33 Million | -10.79 Million |
| Cost and Expenses | 18.13 Billion | 24.6 Billion | 21.9 Billion | 17.59 Billion | 15.83 Billion | 13.9 Billion |
| Operating Income | 7.14 Billion | 2.56 Billion | 2.88 Billion | 3.88 Billion | 2.13 Billion | 1.66 Billion |
| Interest Expense | 378.88 Million | 332.9 Million | 207.47 Million | 229.57 Million | 337.25 Million | 399.58 Million |
| Income Tax Expense | 639.37 Million | 578.2 Million | 649.59 Million | 886.15 Million | 438.9 Million | 412.71 Million |
| Earnings before Tax | 2.35 Billion | 2.24 Billion | 2.69 Billion | 3.69 Billion | 1.85 Billion | 1.31 Billion |
| Net Income | 1.71 Billion | 1.66 Billion | 2.05 Billion | 2.8 Billion | 1.41 Billion | 897.51 Million |
| Earnings Per Share Basic | 18.56 | 17.96 | 22.14 | 30.09 | 15.17 | 9.51 |
| Earnings Per Share Diluted | 18.65 | 17.96 | 22.14 | 30.09 | 15.17 | 9.51 |
| Weighted Average Shares Outstanding | 92.35 Million | 92.6 Million | 92.6 Million | 93.2 Million | 93.2 Million | 94.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.93 Million | 92.6 Million | 92.6 Million | 93.2 Million | 93.2 Million | 94.32 Million |
| Gross Margin | 0.33 | 0.30 | 0.20 | 0.28 | 0.22 | 0.20 |
| EBIT Margin | 0.13 | 0.11 | 0.14 | 0.21 | 0.15 | 0.13 |
| Profit Margin | 0.07 | 0.06 | 0.08 | 0.13 | 0.08 | 0.06 |
| EBITDA | 3.24 Billion | 3.11 Billion | 3.43 Billion | 4.45 Billion | 2.71 Billion | 2.17 Billion |
| Earnings Before Tax Margin | 0.28 | 0.09 | 0.12 | 0.18 | 0.12 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.98 Billion | 5.55 Billion | 25.28 Billion | 6.19 Billion | 6.05 Billion | 6.41 Billion |
| Cost of Revenue | 3.94 Billion | 3.99 Billion | 18.31 Billion | 4.36 Billion | 4.05 Billion | 4.29 Billion |
| Gross Profit | 2.04 Billion | 1.55 Billion | 6.97 Billion | 1.83 Billion | 2 Billion | 2.12 Billion |
| Operating Expenses | 1.51 Billion | 1.04 Billion | 4.32 Billion | 1.11 Billion | 1.43 Billion | 1.48 Billion |
| Selling, General and Administrative Expenses | 1.1 Billion | 1.04 Billion | - | 1.11 Billion | 1.05 Billion | 1.1 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.51 Billion | 11.1 Million | 40.3 Million | 10.8 Million | 16.7 Million | 6.9 Million |
| Cost and Expenses | 5.45 Billion | 5.03 Billion | 22.63 Billion | 5.47 Billion | 5.48 Billion | 5.77 Billion |
| Operating Income | 533.2 Million | 515.7 Million | 2.65 Billion | 722.3 Million | 591.5 Million | 645.2 Million |
| Interest Expense | 89.3 Million | 87.1 Million | 335.2 Million | 91.3 Million | 76 Million | 82.5 Million |
| Income Tax Expense | 109.2 Million | 107.1 Million | 639.4 Million | 168.7 Million | 148.4 Million | 166.6 Million |
| Earnings before Tax | 458.8 Million | 439.8 Million | 2.35 Billion | 641.8 Million | 515.5 Million | 562.7 Million |
| Net Income | 350.1 Million | 332.4 Million | 1.71 Billion | 473.1 Million | 366.7 Million | 395.9 Million |
| Earnings Per Share Basic | 3.83 | 3.62 | - | 5.15 | 3.99 | 4.29 |
| Earnings Per Share Diluted | 3.83 | 3.62 | - | 5.15 | 3.99 | 4.29 |
| Weighted Average Shares Outstanding | 91.27 Million | 91.94 Million | 92.35 Million | 91.98 Million | 91.93 Million | 92.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 91.27 Million | 91.94 Million | 91.94 Million | 91.94 Million | 91.93 Million | 92.28 Million |
| Gross Margin | 0.34 | 0.28 | 0.28 | 0.30 | 0.33 | 0.33 |
| EBIT Margin | 0.11 | 0.12 | - | 0.14 | 0.12 | 0.12 |
| Profit Margin | 0.06 | 0.06 | 0.07 | 0.08 | 0.06 | 0.06 |
| EBITDA | 685.3 Million | 649.5 Million | - | 858.1 Million | 718.1 Million | 771.3 Million |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.10 | 0.12 | 0.10 | 0.10 |
IRRA
300214
ZEAL
NKT
WIX
BUD